Atrophy Clinical Trial - Long-Term Safety of Ospemifene 60 mg Oral Daily

See also
Status	Clinical Trial	Phase
Completed	`NCT02781623` - Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture
Completed	`NCT02497547` - An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy	Phase 2
Completed	`NCT02332343` - Sparing of the Fovea in Geographic Atrophy Progression	N/A
Completed	`NCT00566982` - A Clinical Study to Evaluate the Safety of Ospemifene	Phase 3
Active, not recruiting	`NCT05698316` - A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression
Recruiting	`NCT05869812` - Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes	Phase 2
Completed	`NCT02747641` - Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects	N/A
Completed	`NCT02770365` - Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy	Phase 3
Recruiting	`NCT02137824` - A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients	N/A
Completed	`NCT01585558` - Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus	Phase 3
Completed	`NCT02868749` - Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue	N/A
Recruiting	`NCT01911312` - Evaluation of Thermal-Aided Muscle Stimulation	N/A
Completed	`NCT00729469` - Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity	Phase 3
Completed	`NCT01553773` - Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment	Phase 2
Recruiting	`NCT02745366` - Buccal Fat Pad Derived Stem Cells With Cortical Tenting in Posterior Mandible Reconstruction	Phase 1
Completed	`NCT00807508` - Leucine Supplementation in Elderly Men	Phase 1/Phase 2
Completed	`NCT00744094` - Resistance Training in Elderly	Phase 1/Phase 2
Terminated	`NCT00267839` - Effect of Exercise on Risk-factors of Elderly Women	Phase 3
Terminated	`NCT00292916` - Effect of Whole Body Vibration on Bone and Fall Related Parameters	Phase 3
Completed	`NCT00276094` - A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women	Phase 3

NCT number	NCT01586364
Study type	Interventional
Source	Shionogi Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	May 8, 2006
Completion date	December 22, 2008

Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms